CIK 0000805928
- Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411301878
- Phone
- +1 386-462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-21 | Zaderej Karen L. CEO | Sale | −33,028 | $7.68 | $254K | 1,124,565 |
| 2024-03-21 | Zaderej Karen L. CEO | Sale | −3,086 | $7.68 | $24K | 1,133,979 |
| 2024-03-21 | Zaderej Karen L. CEO | Sale | −3,166 | $7.68 | $24K | 1,143,788 |
| 2024-03-21 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −716 | $7.68 | $5K | 165,661 |
| 2024-03-21 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −721 | $7.68 | $6K | 167,890 |
| 2024-03-21 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −3,141 | $7.68 | $24K | 177,474 |
| 2024-03-21 | Scopelianos Angelo Chief R&D Officer | Sale | −5,251 | $7.68 | $40K | 52,999 |
| 2024-03-21 | Scopelianos Angelo Chief R&D Officer | Sale | −1,020 | $7.68 | $8K | 56,104 |
| 2024-03-21 | Scopelianos Angelo Chief R&D Officer | Sale | −610 | $7.68 | $5K | 57,994 |
| 2024-03-21 | Donovan Michael Patrick VP Operations | Sale | −716 | $7.68 | $5K | 37,992 |
| 2024-03-21 | Donovan Michael Patrick VP Operations | Sale | −721 | $7.68 | $6K | 40,221 |
| 2024-03-21 | Donovan Michael Patrick VP Operations | Sale | −4,596 | $7.68 | $35K | 54,250 |
| 2024-03-07 | Donovan Michael Patrick VP Operations | Sale | −36,310 | $8.81 | $320K | 35,708 |
| 2024-03-07 | Freitag Gregory Gene Director | Sale | −25,000 | $9.00 | $225K | 271,594 |
| 2023-12-11 | MARIANI PETER J EVP & Chief Financial Officer | Sale | −1,410 | $7.52 | $11K | 74,693 |
| 2023-12-11 | MARIANI PETER J EVP & Chief Financial Officer | Sale | −3,120 | $7.51 | $23K | 71,573 |
| 2023-12-11 | MARIANI PETER J EVP & Chief Financial Officer | Sale | −7,970 | $7.50 | $60K | 63,603 |
| 2023-06-01 | Freitag Gregory Gene Director | Sale | −12,500 | $8.65 | $108K | 319,615 |
| 2023-06-01 | Freitag Gregory Gene Director | Sale | −29,480 | $8.74 | $258K | 290,135 |
| 2023-05-23 | Freitag Gregory Gene Director | Sale | −2,828 | $9.17 | $26K | 336,755 |
Page 4 of 9 · 167 trades